Biography Peter Gmeiner
Biography
Prof. Dr. Peter Gmeiner (*30.05.1959) received his Ph.D. in 1986 from the University of Munich. From 1987 to 1988 he was a postdoc at the University of California in Berkeley, USA. He subsequently returned to Munich as a research associate at the Institute of Pharmaceutical Chemistry. Upon receiving his Dr. habilitus in 1992, for which he was honored with the Johann-Wolfgang-Döberreiner prize of the DPhG (1993), he was appointed at the University of Bonn as a Professor of Pharmaceutical Chemistry declining an offer for a professorship at the University of Heidelberg, at the same time. Since October 1996, he has been chaired Full Professor of Pharmaceutical / Medicinal Chemistry at the Friedrich-Alexander University Erlangen-Nürnberg (FAU). In 2000, he declined an offer for the Chair of Pharmaceutical Chemistry at the University of Münster. From 2000 to 2002, he was a Senator at FAU. 2003-2010, he was a board member of the Medicinal Chemistry Section of the German Chemical Society (GDCh). 2008-2019, Peter Gmeiner has been chairman of the Pharmaceutical / Medicinal Chemistry Section of the German Pharmaceutical Society (DPhG). 2008-2012, he was the speaker of the Emil Fischer Graduate Programme in Pharmaceutical Sciences & Molecular Medicine (EFS). 2017-2019, Peter Gmeiner has been the Chairman of the Department of Chemistry and Pharmacy and Vice-Dean of the Faculty of Natural Science. Peter Gmeiner has been the spokesman of the Research Training Group „Medicinal Chemistry of Selective GPCR Ligands“ (GRK 1910). Peter Gmeiner is a co-founder and consultant of the company Epiodyne, Inc and a recipient of a Reinhart Koselleck Programme grant from the German Research Foundation (DFG).
Peter Gmeiner has a track record of more than 350 publications in peer-reviewed scientific journals (including Nature, Science, Cell, PNAS, Angew. Chem., J. Med. Chem., etc.) as well as patents and patent applications. He is an invited speaker at international conferences and has given more than 100 invited talks. Peter Gmeiner serves as referee for the Deutsche Forschungsgemeinschaft (DFG), the Alexander von Humboldt-Foundation (AvH), the Studienstiftung des deutschen Volkes, the DAAD and more than 20 top-ranked journals in the fields of Chemistry and Pharmacology. He is an Editorial and Advisory Board Member of a number of international journals including Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters. In 2023 Peter Gmeiner was awarded the Carl Mannich Medal by the German Pharmaceutical Society (DPhG) for outstanding achievements in the field of pharmaceutical sciences. Peter Gmeiner’s research spans the structure-based design, synthesis and pharmacological investigation of bioactive molecules addressing G-protein coupled receptors (GPCRs) focusing on aminergic and peptidergic receptors.